1 available, 1 terminated. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Terminated 1 |
Follow Molgramostim nebulizer solution: new trials by email Literature Review of Molgramostim nebulizer solution trials Research Report on Molgramostim nebulizer solution
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Inhaled Molgramostim in Cystic Fibrosis Subjects With Nontuberculous Mycobacterial Infection Molgramostim nebulizer solution, PARI eFlow nebulizer system - Mycobacterium Infections, Nontuberculous, Cystic Fibrosis (CF) | Phase 2 | Terminated | Savara Inc. | 14 | 2019-06-20 | 2023-01-10 |
| Molgramostim Nebulizer Solution Expanded Access Program Protocol Molgramostim nebulizer solution - Autoimmune Pulmonary Alveolar Proteinosis | Available | Savara Inc. | 2026-10-26 |
Cystic Fibrosis (1) · Mycobacterium Infections, Nontuberculous (1) · Pulmonary Alveolar Proteinosis (1) · Pulmonary Alveolar Proteinosis, Acquired (1)
Savara Inc. (2)
United States (2)
Jerry Nick, MD (1)